PriceTargets.com logo

eHealth - EHTH Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $3.50
  • Forecasted Upside: -21.88%
  • Number of Analysts: 2
  • Breakdown:
  • 0 Sell Ratings
  • 2 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$4.48 As of 10/4/2024 01:00 AM ET
▲ +0.36 (8.74%)

This chart shows the closing price for EHTH by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New eHealth Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for EHTH and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for EHTH

Analyst Price Target is $3.50
▼ -21.88% Downside Potential
This price target is based on 2 analysts offering 12 month price targets for eHealth in the last 3 months. The average price target is $3.50, with a high forecast of $5.00 and a low forecast of $2.00. The average price target represents a -21.88% upside from the last price of $4.48.

This chart shows the closing price for EHTH for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Hold

The current consensus among 2 contributing investment analysts is to hold stock in eHealth. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 4 hold ratings
  • 0 sell ratings
Ratings as of
4/13/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 4 hold ratings
  • 0 sell ratings
Ratings as of
7/12/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 4 hold ratings
  • 0 sell ratings
Ratings as of
10/10/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 4 hold ratings
  • 0 sell ratings
Ratings as of
1/8/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 4 hold ratings
  • 0 sell ratings
Ratings as of
4/7/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 4 hold ratings
  • 0 sell ratings
Ratings as of
7/6/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
9/4/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
10/4/2024

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
8/14/2024Deutsche Bank AktiengesellschaftLower TargetHold ➝ Hold$5.00 ➝ $2.00
8/8/2024Craig HallumLower TargetHold ➝ Hold$6.00 ➝ $5.00
1/18/2024Craig HallumDowngradeBuy ➝ Hold$7.00
8/14/2023Royal Bank of CanadaReiterated RatingSector Perform ➝ Sector Perform$13.00
8/9/2023CitigroupBoost TargetNeutral ➝ Neutral$9.00 ➝ $10.00
8/9/2023Deutsche Bank AktiengesellschaftBoost TargetHold ➝ Hold$5.00 ➝ $10.00
3/8/2023CitigroupBoost TargetNeutral$4.50 ➝ $10.00
3/6/2023Royal Bank of CanadaLower TargetSector Perform$16.00 ➝ $13.00
3/6/2023Credit Suisse GroupBoost TargetNeutral$4.00 ➝ $10.00
3/1/2023Craig HallumBoost Target$6.00 ➝ $11.00
12/1/2022Craig HallumUpgradeHold ➝ Buy$6.00
11/24/2022Credit Suisse GroupSet Target$4.00
11/15/2022Craig HallumLower Target$6.00
11/15/2022CitigroupLower Target$9.00 ➝ $4.50
11/9/2022Deutsche Bank AktiengesellschaftLower Target$10.00 ➝ $4.00
11/8/2022Truist FinancialLower Target$8.00 ➝ $3.00
8/15/2022Evercore ISILower Target$8.50
8/15/2022Credit Suisse GroupLower TargetNeutral$13.00 ➝ $10.00
8/9/2022Truist FinancialLower TargetHold$12.00 ➝ $8.00
8/9/2022Royal Bank of CanadaLower TargetSector Perform$17.00 ➝ $16.00
8/9/2022CitigroupLower Target$13.00 ➝ $9.00
5/5/2022Deutsche Bank AktiengesellschaftLower Target$19.00 ➝ $10.00
3/21/2022CitigroupDowngradeBuy ➝ Neutral$37.00 ➝ $15.00
3/3/2022Credit Suisse GroupLower TargetNeutral$31.00 ➝ $16.00
3/2/2022Craig HallumLower Target$33.00 ➝ $15.00
3/2/2022Truist FinancialDowngradeBuy ➝ Hold$15.00
1/18/2022BarclaysDowngradeOverweight ➝ Equal Weight$22.00
1/7/2022Credit Suisse GroupDowngradeOutperform ➝ Neutral$45.00 ➝ $31.00
12/20/2021CitigroupLower TargetBuy$45.00 ➝ $37.00
11/29/2021Deutsche Bank AktiengesellschaftLower TargetHold$86.00 ➝ $19.00
11/10/2021Credit Suisse GroupLower TargetOutperform$59.00 ➝ $45.00
11/9/2021Truist FinancialLower TargetBuy$100.00 ➝ $40.00
11/9/2021Craig HallumDowngradeBuy ➝ Hold$75.00 ➝ $33.00
11/9/2021Royal Bank of CanadaLower TargetSector Perform$62.00 ➝ $28.00
7/30/2021Craig HallumBoost TargetBuy$75.00 ➝ $85.00
7/30/2021Credit Suisse GroupLower TargetOutperform$90.00 ➝ $75.00
7/30/2021Royal Bank of CanadaLower TargetSector Perform$70.00 ➝ $62.00
4/30/2021Credit Suisse GroupBoost TargetOutperform$78.00 ➝ $90.00
4/30/2021BarclaysBoost TargetPositive ➝ Overweight$75.00 ➝ $80.00
3/31/2021The Goldman Sachs GroupReiterated RatingBuy ➝ Neutral$63.00
3/30/2021Craig HallumBoost TargetBuy$65.00 ➝ $85.00
3/25/2021The Goldman Sachs GroupDowngradeBuy ➝ Neutral$63.00
3/23/2021Credit Suisse GroupBoost TargetOutperform$63.00 ➝ $78.00
3/23/2021Evercore ISIBoost TargetPositive ➝ Outperform$60.00 ➝ $80.00
2/25/2021Deutsche Bank AktiengesellschaftReiterated RatingBuy ➝ Hold$63.00
2/24/2021Raymond JamesReiterated RatingHold
2/19/2021Deutsche Bank AktiengesellschaftDowngradeBuy ➝ Hold$124.00 ➝ $63.00
2/2/2021The Goldman Sachs GroupLower TargetBuy$101.00 ➝ $64.00
2/1/2021Truist FinancialLower Target$200.00 ➝ $100.00
2/1/2021Craig HallumLower TargetBuy$150.00 ➝ $65.00
2/1/2021Raymond JamesDowngradeOutperform ➝ Market Perform
2/1/2021BarclaysLower TargetOverweight$115.00 ➝ $75.00
1/29/2021Royal Bank of CanadaDowngradeOutperform ➝ Sector Perform
12/14/2020Leerink PartnersLower TargetOutperform$110.00 ➝ $105.00
10/23/2020Deutsche Bank AktiengesellschaftLower TargetBuy$138.00 ➝ $124.00
10/2/2020Raymond JamesReiterated RatingBuy
9/25/2020The Goldman Sachs GroupInitiated CoverageBuy$101.00
9/8/2020Leerink PartnersUpgradeMarket Perform ➝ Outperform$110.00
8/6/2020Credit Suisse GroupReiterated RatingBuy$130.00
7/27/2020Raymond JamesLower TargetOutperform$165.00 ➝ $115.00
7/24/2020SunTrust BanksLower Target$250.00 ➝ $200.00
7/24/2020Craig HallumLower TargetBuy$200.00 ➝ $150.00
7/24/2020Credit Suisse GroupLower TargetOutperform$174.00 ➝ $156.00
7/24/2020Leerink PartnersBoost TargetMarket Perform$108.00 ➝ $110.00
7/24/2020Deutsche Bank AktiengesellschaftBoost TargetBuy$138.00 ➝ $170.00
7/24/2020Royal Bank of CanadaBoost TargetOutperform$127.00 ➝ $166.00
7/24/2020CitigroupLower TargetBuy$135.00 ➝ $125.00
7/24/2020BarclaysLower TargetMarket Perform ➝ Overweight$150.00 ➝ $140.00
7/14/2020CitigroupInitiated CoverageBuy$135.00
7/1/2020Leerink PartnersInitiated CoverageMarket Perform$108.00
6/15/2020Evercore ISIInitiated CoverageBuy$150.00
4/29/2020Cantor FitzgeraldReiterated RatingBuy$185.00
4/27/2020Deutsche Bank AktiengesellschaftLower TargetBuy$177.00 ➝ $170.00
4/24/2020SunTrust BanksReiterated RatingBuy$250.00
4/24/2020Credit Suisse GroupInitiated CoverageBuy$174.00
4/16/2020BarclaysInitiated CoverageOverweight$150.00
2/24/2020SunTrust BanksBoost TargetBuy$200.00 ➝ $250.00
2/24/2020Credit Suisse GroupBoost TargetBuy ➝ Outperform$145.00 ➝ $179.00
2/21/2020Craig HallumBoost TargetBuy$150.00 ➝ $200.00
2/21/2020Deutsche Bank AktiengesellschaftBoost TargetBuy$163.00 ➝ $177.00
2/21/2020Royal Bank of CanadaBoost TargetOutperform$132.00 ➝ $166.00
2/21/2020Cantor FitzgeraldReiterated RatingOverweight$150.00 ➝ $185.00
2/18/2020SunTrust BanksReiterated RatingBuy$200.00
1/28/2020Raymond JamesBoost TargetOutperform$90.00 ➝ $135.00
1/24/2020Craig HallumBoost TargetBuy$110.00 ➝ $150.00
1/24/2020Credit Suisse GroupBoost TargetOutperform$134.00 ➝ $145.00
1/24/2020Royal Bank of CanadaBoost TargetOutperform$111.00 ➝ $132.00
1/24/2020Cantor FitzgeraldReiterated RatingOverweight$120.00 ➝ $150.00
1/17/2020SunTrust BanksReiterated RatingBuy$200.00
10/25/2019Cantor FitzgeraldSet TargetBuy$120.00
10/25/2019Royal Bank of CanadaSet TargetBuy$111.00
10/25/2019Raymond JamesSet TargetBuy$90.00
10/14/2019Raymond JamesInitiated CoverageOutperform$90.00
(Data available from 10/4/2019 forward)

News Sentiment Rating

0.22 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 4 very positive mentions
  • 21 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
Mentions as of
3/8/2024
  • 2 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/7/2024
  • 2 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/7/2024
  • 5 very positive mentions
  • 5 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
6/6/2024
  • 3 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/6/2024
  • 1 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/5/2024
  • 3 very positive mentions
  • 16 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
9/4/2024
  • 0 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/4/2024

Current Sentiment

  • 0 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

eHealth logo
eHealth, Inc. operates a health insurance marketplace that provides consumer engagement, education, and health insurance enrollment solutions in the United States. The company operates in two segments, Medicare; and Employer and Individual. The Medicare segment offers sale of Medicare-related health insurance plans, which includes Medicare advantage, Medicare Supplement, and Medicare Part D prescription drug plans to Medicare-eligible customers including but not limited to, dental, and vision insurance, as well as advertising program for marketing and other services. The Employer and Individual segment engages in the sale of individual, family, and small business health insurance plans; and ancillary products to non-Medicare-eligible customers including but not limited to, dental, vision, and short and long term disability insurance. In addition, the company provides ecommerce platforms and consumer engagement solutions, which includes market leading information, decision support, customer engagement, and transactional services to group of health insurance consumers; and organize and present the insurance information in objective format to individuals, families, and small businesses to research, analyze, compare and purchase health insurance plans. Further, it markets health insurance plans through its websites, including eHealth.com, eHealthInsurance.com, eHealthMedicare.com, Medicare.com, PlanPrescriber.com, and GoMedigap.com. The company also offers online sponsorship and advertising, non-broker of record, lead referral, technology licensing, as well as performs various post-enrollment services for members in Medicare health insurance plans. eHealth, Inc. was incorporated in 1997 and is headquartered in Austin, Texas.
Read More

Today's Range

Now: $4.48
Low: $4.15
High: $4.51

50 Day Range

MA: $4.19
Low: $3.60
High: $5.41

52 Week Range

Now: $4.48
Low: $3.58
High: $9.45

Volume

197,380 shs

Average Volume

272,834 shs

Market Capitalization

$130.47 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.53

Frequently Asked Questions

What sell-side analysts currently cover shares of eHealth?

The following sell-side analysts have issued research reports on eHealth in the last twelve months: Craig Hallum, Deutsche Bank Aktiengesellschaft, and StockNews.com.
View the latest analyst ratings for EHTH.

What is the current price target for eHealth?

2 Wall Street analysts have set twelve-month price targets for eHealth in the last year. Their average twelve-month price target is $3.50, suggesting a possible downside of 20.3%. Craig Hallum has the highest price target set, predicting EHTH will reach $5.00 in the next twelve months. Deutsche Bank Aktiengesellschaft has the lowest price target set, forecasting a price of $2.00 for eHealth in the next year.
View the latest price targets for EHTH.

What is the current consensus analyst rating for eHealth?

eHealth currently has 2 hold ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in EHTH, but not buy more shares or sell existing shares.
View the latest ratings for EHTH.

What other companies compete with eHealth?

Other companies that are similar to eHealth include Health Insurance Innovations, Crawford & Company, Marsh & McLennan Companies, AON and Arthur J. Gallagher & Co.. Learn More about companies similar to eHealth.

How do I contact eHealth's investor relations team?

eHealth's physical mailing address is 2625 AUGUSTINE DRIVE SECOND FLOOR, SANTA CLARA CA, 95054. The financial services provider's listed phone number is (650) 210-3150 and its investor relations email address is [email protected]. The official website for eHealth is www.ehealthinsurance.com. Learn More about contacing eHealth investor relations.